In pathological situations, PSMA is primarily expressed in the human prostate epithelium, salivary and lacrimal glands and kidneys with enhanced expression by almost all prostate cancers and further up-regulation in poorly differentiated, metastatic and hormone-refractory carcinomas without being shed into the circulation [5,14]. This evidence concerns the gene FOLH1 and prostate cancer.